General Information
Revision date
2001-02-09
Product name
Methergine Injection, USP
Product Synonyms
Ergot alkaloid
Chemical name
Ergoline-8-carboxamide,9,10-didehydro-N-[1-(hydroxymethyl)propyl]-6-methyl- ,[8(S)]-,(Z)-2-butenedioate (1:1) (salt)
CAS No.
57432-61-8
Icons in SDS
Company Information
company name
NOVARTIS PHARMACEUTICALS CORPORATION
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW *************************************************************************************************** FINISHED PHARMACEUTICAL PRODUCT REFER TO PHYSICIANS' DESK REFERENCE ***************************************************************************************************
Principle Routes of Exposure
Injection EFFECTS OF OVEREXPOSURE: Finished pharmaceutical product. Potential for exposure is reduced in this form. Skin: No hazard is expected from normal clinical use. Eye: No hazard is expected from normal clinical use. Inhalation: No hazard is expected from normal clinical use. Ingestion: No hazard is expected from normal clinical use. THERAPEUTIC SIDE EFFECTS: Hypertension, seizures, headaches, hypotension, nausea, and vomiting. TARGET ORGAN EFFECTS: No information at this time. REPRODUCTIVE HAZARDS: No information at this time. CARCINOGENICITY: No information at this time. MUTAGENICITY: No information at this time.
Medical Conditions Generally Aggravated by Exposure
Individuals with hypertension, Pregnancy, Toximia
